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Kinases are a major class of drug targets and are involved
in a variety of diseases such as diabetes, cancer and inflam-
mation. Still, understanding kinase inhibitor selectivity and
promiscuity remains a major challenge. In order to
improve upon the current situation, we analyzed a dataset
comprising 157 compounds, tested at concentrations of
1 μM and 10 μM against a panel of 225 human protein
kinases. Our bioactivity-based classification of kinases
shows similarities with the Sugen sequence-based classifi-
cation [1], where particularly kinases from the TK, CDK,
CLK and AGC groups cluster together. However, 57% of
all kinase pairs inhibited by 6 known inhibitors consist of
kinases which lie far apart from each other in the Sugen
tree (relative distance of 0.6 - 0.8 on a scale from 0 to 1),
but are correctly located closer to each other in our
bioactivity-based tree (distance 0 - 0.4). For 80% of all ana-
lyzed kinases, those classified as neighbors according to
the bioactivity-based classification also show high similar-
ity in shared active compounds. However, among the
remaining ~20%, distant kinases did not necessarily show
low SAR similarity, and neighboring kinases did not neces-
sarily show high SAR similarity; i.e., the placement in the
tree was misleading. We identified two reasons for this:
firstly, ‘misplaced’ kinases exhibit inconsistent SAR, and
secondly, these kinases had only a few shared activities
with other kinases, making both the computation of their
bioactivity-based distance and their place in the tree less
accurate. In a follow-up analysis, we resolved both pro-
blems by visualizing inconsistent SAR more accurately
using MDS plots, rather than phylogenetic trees, and by
excluding kinases with 16 or fewer shared activities. Only
7 kinases (4% of the kinases analyzed) did not show a clear
relationship between kinase bioactivity profile similarity
and shared active compounds. Hence, this analysis
improves on previous studies, where the influence of data
density on kinase similarity was not considered, and leads
to a more reliable placement of kinases into the kinome
tree. Overall, our analysis suggests that bioactivity-based
classification of kinases is indeed more useful than
sequence-based classification for predicting kinase-inhibi-
tor interactions. However, care needs to be taken with
respect to data density (i.e., kinases with too few data
points need to be omitted) and visualization of the data
(i.e., phylogenetic trees imply a neighborhood relationship
that is not consistently observed in every case).
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